ROIV Roivant Sciences Ltd.

$31.40 +0.67%

Healthcare · Pharmaceutical Preparations

Roivant Sciences Ltd. (ROIV) is a healthcare company in the Pharmaceutical Preparations industry, with a market capitalization of $22.6 billion. Shares last traded at $31.40, 4.2% below their 52-week high. Over the past year the stock is up 182.6%. Net profit margin is -3629.2%, below the peer median of -0.1%. Revenue declined 71.6% year over year.

Market Cap

$22.6B

Shares Out

719.3M

EPS (TTM)

$-1.65

P/E Ratio

—

P/S Ratio

2734.27

P/B Ratio

4.99

Dividend / Share

—

Dividend Yield

—

52-Week High

$32.78

52-Week Low

$10.70

Volume

300,807

Avg Vol (3m)

360,935.714

Performance

+5.62%

+11.35%

+12.97%

+36.94%

YTD

+43.22%

+182.63%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

62.26

SMA (50)

$29.13

SMA (200)

$23.56

Price vs SMA50

+7.80%

Price vs SMA200

+33.30%

ATR (14)

$1.09

Financials

Revenue

$8M

Net Income

$-300M

Gross Margin

—

Operating Margin

-6235.7%

Net Margin

-3629.2%

Return on Equity

-6.6%

Return on Assets

-5.3%

Current Ratio

18.37

Debt / Equity

0.07

Revenue Growth (YoY)

-71.6%

Latest reported annual period ending 2026-03-31 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
FY 2025	$-0.54	2026-05-20
Q3 2025	$-0.88	2026-02-06
Q2 2025	$-0.49	2025-11-10
Q1 2025	$-0.33	2025-08-11
FY 2025	$-0.24	2026-05-20
Q3 2025	$0.05	2026-02-06

Full earnings history →

Pharmaceutical Preparations peers

ROIV vs 14 industry peers (Pharmaceutical Preparations), by market cap.

P/S vs peers

2734.27 / 3.54 med

+77191% premium

Net margin vs peers

-3629.2% / -0.1% med

below median

1–14 of 14


LLY	Lilly (Eli)	$1.04T	50.16	15.88	31.7%	-1.17%
JNJ	Johnson & Johnson	$549.8B	20.51	5.84	28.5%	-2.42%
ONC	Beone Medicines Ltd.	$390.6B	1361.26	73.10	5.4%	+2.83%
ABBV	AbbVie	$382.5B	90.51	6.25	6.9%	-2.16%
MRK	Merck	$281.6B	15.43	4.33	28.1%	-1.30%
ABT	Abbott Laboratories	$154.3B	23.65	3.48	14.7%	+0.09%
PFE	Pfizer	$143.7B	18.50	2.30	12.4%	-2.89%
VRTX	Vertex Pharmaceuticals	$114.6B	28.99	9.55	32.9%	-1.63%
BMY	Bristol Myers Squibb	$110.3B	15.63	2.29	14.6%	-2.35%
REGN	Regeneron Pharmaceuticals	$63.4B	14.08	4.42	31.4%	+0.38%
ALNY	Alnylam Pharmaceuticals	$36.9B	117.57	9.93	8.4%	-1.66%
TEVA	Teva Pharmaceutical Industries Ltd	$36.6B	25.98	2.12	8.2%	-3.33%
ZTS	Zoetis	$33.1B	12.37	3.49	28.2%	+2.09%
RPRX	Royalty Pharma Plc	$23.1B	30.02	9.73	32.4%	-1.30%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.